by Lisa Willemse | Jun 2, 2015
. A clinical trial set to begin this month in Ottawa will test the safety and efficacy of mesenchymal stem cells to stimulate repair of damaged nerves in MS patients. This article was published simultaneously on the Ontario Institute for Regenerative Medicine website....
by Mark Curtis | May 27, 2015
. Welcome to your deal review for the month of April. There is no update yet on the fate of the Cellular Dynamics International/Fujifilm deal, but it appears that CDI made some effort to solicit offers from alternative bidders. Aduro made headlines, though, closing a...
by Mark Curtis | May 25, 2015
. Welcome to your Update from the Clinic for the month of April. Mesenchymal stem cells took a hit as Athersys’ MultiStem came up short, missing its primary endpoint in a Phase 2 study investigating the cells for ischemic stroke. Juno Therapeutics continues to turn...
by Paul Krzyzanowski | May 21, 2015
. By now, many of you will have heard of Fujifilm’s USD$307 million purchase of Cellullar Dynamics International (CDI). This may seem like a major entry into the regenerative medicine (RM) space for a company that’s better known for its imaging technologies than...
by Mark Curtis | Apr 28, 2015
. After several years of intense systematic research, and toiling with a differentiation protocol, Dr. Doug Melton, and his lab at Harvard University, finally decoded the sequence of genes that needs to be activated to yield mature, insulin-producing beta cells in...
Comments